The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

< Previous | 2025 Agenda and Abstracts | Next >

 

2025 OMIG Abstract

Real World Deployment of an AI Model for Potassium Hydroxide Smear Interpretation Reveals Critical Implementation Barriers

Jad F. Assaf1, Hady Yazbeck1, Phit Upaphong1, John Jackson1, Prajna N. Venkatesh2, Lalitha Prajna3, Ramesh Gunasekaran3, Karpagam Rajarathinam3, Thomas M Lietman4, Jeremy D Keenan4,
J Peter Campbell1, Xubo Song5, Travis K Redd1*


1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon; 2Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Madurai, India; 3Department of Ocular Microbiology, Aravind Eye Hospital and PG Institute of Ophthalmology, Madurai, Tamil Nadu, India; 4Francis I. Proctor Foundation, University of California San Francisco, California; 5Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon


Purpose: To evaluate the field performance of a previously validated dual stream multiple instance learning network (79% slide level accuracy during development in Madurai, India) for detecting filamentous fungus on potassium hydroxide (KOH) corneal smears, and to identify real world factors responsible for performance degradation.

Methods: Prospective, multicenter implementation study (May–July 2025) at three Aravind Eye Hospital sites (Coimbatore, Pondicherry, Madurai). The trained model was integrated into manual whole slide imaging (WSI) workstations running Microvisioneer MvSlide. Corneal scrape smears were digitized at 20x magnification. WSI-based AI predictions (fungus +/–) were compared with reference standard light microscopy performed through binoculars. The primary endpoint was slide level accuracy. Secondary analyses assessed operator level accuracy and the proportion of human interpretations revised after reviewing the AI classification and its probability heat map overlays. We used root cause analysis to explore drivers of performance loss.

Results: A total of 112 smears were processed (18 Coimbatore, 17 Pondicherry, 77 Madurai). Overall AI accuracy declined to 58.9% (66/112), a 20-point drop from the 79% development benchmark. Site specific AI accuracy was 38.9% (Coimbatore), 52.9% (Pondicherry), and 64.9% (Madurai), with operator level accuracy ranging from 51% to 68%. Only 2.7% (3/111) of human reads changed after viewing AI output, all downgrading fungus-positive slides to “indeterminate.” False predictions were linked to modifiable factors: loss of focus during manual scanning, air bubble artifacts from sub optimal coverslip placement, imaging delays exceeding 24h, improper shading correction and color calibration, tracking errors in MvSlide, use of 10x instead of 20x objectives, and domain shift due to training the AI model exclusively on high quality scans.

Conclusions: Deploying a high performing KOH smear AI model in routine practice resulted in substantial accuracy loss driven primarily by slide preparation and imaging workflow variability. Standardized protocols for coverslip placement, microscope calibration, and real time quality control are prerequisites for safe scaling. Current work will retrain site specific models incorporating lower quality real world images to improve robustness and close the implementation gap in ocular microbiology.



Disclosure:
N (HY, PU, JJ, PNV, LP, RG, KR, TML, JDK, JPC, XS, TKR);
O (JFA, NeuralVision - FZCO, Dubai, UAE)


Support:
Supported by the National Eye Institute (P30 EY010572, K23 EY032639), Research to Prevent Blindness (Tom Wertheimer Career Development Award in Data Science and unrestricted departmental funding), Collins Medical Trust, and the Malcolm M. Marquis, MD Endowed Fund for Innovation.


< Previous | 2025 Agenda and Abstracts | Next >

 


 

 

space